Avcı Nilufer, Ture Mehmet, Deligonul Adem, Cubukcu Erdem, Olmez Omer Fatih, Sahinturk Serdar, Topak Ali, Kurt Ender, Evrensel Turkkan, Şahin Ahmet Bilgehan, Yakut Tahsin
Department of Medical Oncology, Ali Osman Sonmez Oncology Hospital, Bursa, Turkey,
Pathol Oncol Res. 2015 Sep;21(4):1243-7. doi: 10.1007/s12253-015-9950-7. Epub 2015 Jul 9.
Matrix metalloproteinases (MMPs) are a group of zinc-dependent peptidases that participate in matrix turnover in solid malignancies. The aim of this study was twofold. First, we sought to investigate under a case-control design the association between the functional -1562C/T polymorphism in the promoter region of MMP-9 and gastric cancer (GC) in a Turkish sample. Second, we examined its prognostic significance in GC patients. A total of 144 subjects were enrolled in the case-control study (79 GC cases and 65 controls). Overall survival (OS) and progression-free survival (PFS) served as the main outcome measures in the longitudinal study. The MMP-9 -1562C/T polymorphism was genotyped using a polymerase chain reaction-restriction fragment length polymorphism method. The odds ratio (OR) of GC for the CC genotype relative to the CT+TT genotypes was not significant (OR = 0.89, 95 % confidence interval [CI] = 0.44-1.82, P = 0.75). These results did not change after allowance for age and sex in multivariable regression analysis (OR = 0.81, 95 % CI = 0.40-1.94, P = 0.84). When the MMP-9 -1562C/T polymorphism was analyzed among GC patients in relation to OS and PFS, we found no significant differences between subjects with the CC and CT+TT genotypes. In conclusion, the results of our study did not point toward a major role of the MMP-9 -1562C/T polymorphism in the pathogenesis and clinical course of GC in Turkish subjects.
基质金属蛋白酶(MMPs)是一组锌依赖性肽酶,参与实体恶性肿瘤中的基质更新。本研究有两个目的。首先,我们试图在病例对照设计下,研究土耳其样本中MMP - 9启动子区域功能性 - 1562C/T多态性与胃癌(GC)之间的关联。其次,我们研究了其在GC患者中的预后意义。病例对照研究共纳入144名受试者(79例GC患者和65名对照)。总生存期(OS)和无进展生存期(PFS)作为纵向研究的主要结局指标。采用聚合酶链反应 - 限制性片段长度多态性方法对MMP - 9 - 1562C/T多态性进行基因分型。CC基因型相对于CT + TT基因型的GC比值比(OR)无统计学意义(OR = 0.89,95%置信区间[CI] = 0.44 - 1.82,P = 0.75)。在多变量回归分析中校正年龄和性别后,这些结果没有改变(OR = 0.81,95% CI = 0.40 - 1.94,P = 0.84)。当在GC患者中分析MMP - 9 - 1562C/T多态性与OS和PFS的关系时,我们发现CC基因型和CT + TT基因型的受试者之间没有显著差异。总之,我们的研究结果并未表明MMP - 9 - 1562C/T多态性在土耳其受试者GC的发病机制和临床过程中起主要作用。